Literature DB >> 19449421

van den Ende-Gupta syndrome: evidence for genetic heterogeneity.

Gabriela F Leal1, Elias O Silva.   

Abstract

van den Ende-Gupta syndrome is characterized by craniofacial and skeletal manifestations, mainly malar and/or maxillary hypoplasia, blepharophimosis, distinctive nose, lower lip eversion, arachnodactyly, camptodactyly, and long slender bones of hands and feet. Growth and development are normal. To date only 11 patients, from 8 families, have been described. Autosomal recessive inheritance has been accepted in this condition, supported by the presence of consanguinity in three families and the recurrence of the disorder within the offspring of unaffected couples. In this article we report on a kindred with three affected individuals, two brothers and their half-sister, in which the van den Ende-Gupta syndrome is probably transmitted as an autosomal dominant trait in connection with gonadal mosaicism. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19449421     DOI: 10.1002/ajmg.a.32871

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

1.  Unmasking of a Recessive SCARF2 Mutation by a 22q11.12 de novo Deletion in a Patient with Van den Ende-Gupta Syndrome.

Authors:  M F Bedeschi; L Colombo; F Mari; K Hofmann; A Rauch; B Gentilin; A Renieri; D Clerici
Journal:  Mol Syndromol       Date:  2011-05-18

2.  Mutations in SCARF2 are responsible for Van Den Ende-Gupta syndrome.

Authors:  Natascia Anastasio; Tawfeg Ben-Omran; Ahmad Teebi; Kevin C H Ha; Emilie Lalonde; Rehab Ali; Mariam Almureikhi; Vazken M Der Kaloustian; Junhui Liu; David S Rosenblatt; Jacek Majewski; Loydie A Jerome-Majewska
Journal:  Am J Hum Genet       Date:  2010-10-08       Impact factor: 11.025

3.  Scavenger receptor class F member 2 (SCARF2) as a novel therapeutic target in glioblastoma.

Authors:  Chaeyeong Kim; Gyeyeong Kong; Hyunji Lee; Quangdon Tran; Thuy-Trang T Vo; So Hee Kwon; Jisoo Park; Seon-Hwan Kim; Jongsun Park
Journal:  Toxicol Res       Date:  2022-02-25

4.  Sclerocornea in a patient with van den Ende-Gupta syndrome homozygous for a SCARF2 microdeletion.

Authors:  Michele P Migliavacca; Nara L M Sobreira; Graziela P M Antonialli; Mariana M Oliveira; Maria Isabel S A Melaragno; Ingele Casteels; Thomy de Ravel; Decio Brunoni; David Valle; Ana Beatriz A Perez
Journal:  Am J Med Genet A       Date:  2014-01-29       Impact factor: 2.802

5.  Inclusion of joint laxity, recurrent patellar dislocation, and short distal ulnae as a feature of Van Den Ende-Gupta syndrome: a case report.

Authors:  Mohammad M Al-Qattan; Doaa F Andejani; Nadia A Sakati; Khushnooda Ramzan; Faiqa Imtiaz
Journal:  BMC Med Genet       Date:  2018-01-30       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.